Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
3,204
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study

Hongsheng Zhoua Nanfang Hospital, Southern Medical University, Guangzhou, ChinaView further author information
,
Qingsong Yinb Henan Cancer Hospital, Zhengzhou, ChinaView further author information
,
Jie Jinc The First Affiliated Hospital, College of Medicine, Zhejiang University College of Medicine, Hangzhou, ChinaView further author information
,
Ting Liud West China Hospital, Sichuan University, Chengdu, ChinaView further author information
,
Zhen Caic The First Affiliated Hospital, College of Medicine, Zhejiang University College of Medicine, Hangzhou, ChinaView further author information
,
Bin Jiange Peking University International Hospital, Beijing, ChinaView further author information
,
Dengju Lif Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, ChinaView further author information
,
Zimin Sung Anhui Provincial Hospital, Hefei, ChinaView further author information
,
Yan Lih The First Hospital of China Medical University, Shenyang, ChinaView further author information
,
Yanjuan Hei Xiangya Hospital Central South University, Changsha, ChinaView further author information
,
Liping Maj Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaView further author information
,
Sujun Gaok The First Hospital of Jilin University, Jilin, ChinaView further author information
,
Jianda Hul Fujian Medical University Union Hospital, Fujian, ChinaView further author information
,
Aili Hem The Second Affiliated Hospital of Xian Jiaotong University, Shaanxi, ChinaView further author information
,
Xin Dun Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, ChinaView further author information
,
Daihong Liuo Chinese People Liberation Army General Hospital, Beijing, ChinaView further author information
,
Xiaohong Zhangp The Second Affiliated Hospital Zhejiang University College of Medicine, Zhejiang, ChinaView further author information
,
Xiaoyan Keq Peking University Third Hospital, Beijing, ChinaView further author information
,
Junling Zhuangr Peking Union Medical College Hospital, Beijing, ChinaView further author information
,
Yue Hans The First Affiliated Hospital of Soochow University, Jiangsu, ChinaView further author information
,
Xiaoqin Wangt Huashan Hospital Affiliated to Fudan University, Shanghai, ChinaView further author information
,
Yuqi Chenu Global Biostatistical Sciences, Amgen Inc., Thousand Oaks, CA, USAView further author information
,
Paul Gordonv Global Development, Amgen Inc., Thousand Oaks, CA, USAView further author information
,
Dong Yuw Amgen China, Shanghai, People’s Republic of ChinaView further author information
,
Gerhard Zugmaierx Global Development, Amgen Research (Munich) GmbH, Munich, GermanyView further author information
&
Jianxiang Wangy Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 917-927 | Published online: 24 Aug 2022

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (1)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.